2Muller I,Besta F,Schulz C,et al.Effects of statins on platelet inhibition by a high loading dose of clopidogrel[J].Circulation,2003,108 (18):2195-2197.
3Barragan P,Bouvier JL,Roquebert PO,et al.Resistance to thienopyridines:clinical detection of coronary stent thrombosis bymonitoring of vasodilator stimulated phosphoprotein phosphorylation[J].Catheter Cardiovasc Interv,2003,59 (3):295-302.
4Gurbel PA,B liden KP.Hiatt BL,et al.Clopidogrel for coronary stenting:response variability.drug resistance.and the effect of pretreatment platelet reactivity[J].Circulation.2003.107(23):2908-2913.
5Serebruany VL.Steinhubl SR,Berger PB,et al.Variability in platelet responsiveness to clopidogrel among 544 individuals[J].J Am Coll Cardiol,2005,45(2):246-251.
6Lau WC,Waskell LA,Watkins PB,et al.Atorvastatin reduces the ability of clopidogrel to inhibit p latelet aggregation:a new drug-drug interaction[J].Circulation,2003.107 (1):32-37.
7Clarke TA,Waskell LA.The metabolism of clopidogrel is catalyzed by human cytochrome P450 3A and is inhibited by atorvastatin[J].Drug Metab Dispos,2003,31 (1):53-59.
8Lepantalo A,Virtanen KS,Heikkila J,et al.Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions[J].Eur Heart J,25(6):476-483.
二级参考文献30
1Clarke TA,Waskell LA.The metabolism of clopidogrel is catalyzed by human cytochrome P450 3A and is inhibited by atorvastatin[J].Drug Metab Dispos,2003,31(1):53-59.
2Wienbergen H,Gitt AK,Schiele R,et al.Comparison of clinical benefits of clopidogrel therapy in patients with acute coronary syndromes taking atorvastatin versus other statin therapies[J].Am J Cardiol,2003,92(3):285-288.
3Serebruany VL,Midei MG,Malinin AI,et al.Atorvastatin does not affect the antiplatelet properties of clopidogrel in patients undergoing coronary stenting in randomized data from the interaction of atorvastatin and clopidogrel trial[J].J Am Coll Cardiol,2003,41(2):302A.
4Mitsios JV,Papathanasiou AP,Rodis FI,et al.Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes[J].Circulation,2004,109(11):1335-1338.
5Saw J,Steinhubl SR,Berger PB,et al.Clopidogrel for the reduction of events during observation investigators.Lack of adverse clopidogrel- atorvastatin clinical interaction from secondary analysis of a randomized,placebo-controlled clopidogrel trial[J].Circulation,2003,108(9):921-924.
6Havranek EP,Weinberger J.Concomitant use of angiotensin-converting enzyme(ACE)inhibitors and antiplatelet therapies:clopidogrel versus aspirin[J].J Hypertens,1999,17:S57.
7Lale A,Herbert JM,Savi P.The antiaggregating activity of clopidogrel is not affected by N-acetyl L-cysteine[J].Thromb Haemost,2003,90(5):839-843.
8Muller I,Seyfarth M,Rudiger S,et al.Effect of a high dose of clopidogrel on platelet function in patients undergoing coronary stent placement[J].Heart,2001,85(1):92-93.
9O'Naill WW,Serruys P,Knudtson M,et al.Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularisation[J].N Engl J Med,2000,342(17):1316-1324.
10The 2nd SYMPHONY Investigators.Randomized trial of aspirin,sibrafiban,or both for secondary prevention after acute coronary syndromes[J].Circulation,2001,103(13):1727-1733.
